A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Learn the side effects of missing a dose of Ozempic, Wegovy, and similar drugs. Experts explain potential impacts, risks, and ...

Although constipation and diarrhea may seem like opposite problems, they both hinge on the same underlying issue: how much ...

While influenza remains the top concern for Maine public health experts, other viruses are also currently circulating, ...

Stopping a GLP-1 suddenly, especially after long-term use, may lead to a rapid return of false hunger signals, distracting ...

Although constipation and diarrhea may seem like opposite problems, they both hinge on the same underlying issue: how much fluid moves into the gut. These common issues affect millions of people in ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...

With smart DMPK strategies, cross-domain collaboration, and strong CDMO support, companies are pushing past the challenges of ...

Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...

GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment, but maintaining weight loss after the ...

This article discusses possible warning signs of irritable bowel syndrome and recommendations for evaluation and management.